(Q24187156)

English

Oral steroids for long-term use in cystic fibrosis

scientific article (published 2015-12-09)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Oral steroids for long-term use in cystic fibrosis (English)

0 references

0 references

2

Deborah Ashby

0 references

author name string

Katharine Cheng

series ordinal

1

0 references

Rosalind L Smyth

series ordinal

3

0 references

publication date

9 December 2015

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Statistical aspects of research methodology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Oral steroids for cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Oral steroids for long-term use in cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Oral steroids for long-term use in cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD000407.PUB4

retrieved

21 January 2018

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of corticosteroids in cystic fibrosis lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early pulmonary inflammation in infants with cystic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of alternate-day prednisone in patients with cystic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26649765

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/14651858.CD000407.PUB4

0 references

PMC publication ID

7034414

0 references

PubMed publication ID

26649765

0 references

(Q24187156)

Oral steroids for long-term use in cystic fibrosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)